June 15, 2023
by Illia Petrov
Biopharma insight
Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …
Dec. 26, 2017
by Andrii Buvailo
Interview
Without a doubt, the area of artificial intelligence (AI) has been a sensation lately -- judging by the amount of …
Oct. 27, 2017
by Alfred Ajami
Biopharma insight
In a case of "back to the future", chemists at Scripps collaborating with instrument engineers at IKA have unveiled a …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
May 19, 2019
by Andrii Buvailo
Biopharma insight
Things like gene editing, stem cells, immunotherapies and new types of biologics are now mega-trends in the pharmaceutical industry, widely …
Feb. 19, 2020
by Irina Bilous
Biopharma insight
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
March 15, 2018
by Andrii Buvailo
Biopharma insight
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate …
Dec. 6, 2017
by Alfred Ajami
Biopharma insight
The16th century alchemical and 19th century science fiction revival of a miniature human being in a test tube is undergoing …
April 15, 2021
by Aruna Rajan
Biopharma insight
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
Dec. 18, 2019
by Andrii Buvailo
Interview
The application of artificial intelligence (AI) in the pharmaceutical industry has become a long-term strategic priority for most companies. However, …
Feb. 8, 2019
by Ben Ramsbottom
Biopharma insight
According to a research report by The Business Research Company, the global pharmaceuticals market was worth $934.8 billion in 2017. …